Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 46 Records) |
Query Trace: Syndrome and SF3B1[original query] |
---|
The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome. Asian Pacific journal of cancer prevention : APJCP 2018 Jul 19 (7): 1825-1831. Rujirachaivej Punchita, Siriboonpiputtana Teerapong, Rerkamnuaychoke Budsaba, Magmuang Suthada, Chareonsirisuthigul Takol, Boonsakan Paisarn, Petvises Sawang, Sirirat Tanasan, Niparuck Pimjai, Chuncharunee Supo |
Association of Gene Mutations with Response to Arsenic-Containing Compound Qinghuang Powder () in Patients with Myelodysplastic Syndromes. Chinese journal of integrative medicine 2018 4 25 (6): 409-415. Zhao Pan, Liang Jun-Bin, Deng Zhong-Yang, Wang Ming-Jing, Qin Jia-Yue, Chen Chong-Jian, Hu Xiao-M |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome. Clinical epigenetics 2018 4 10 42. Lin Ming-En, Hou Hsin-An, Tsai Cheng-Hong, Wu Shang-Ju, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Liu Ming-Chih, Liu Chia-Wen, Chou Wen-Chien, Chen Chien-Yuan, Tang Jih-Luh, Yao Ming, Li Chi-Cheng, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Lin Chien-Ting, Tien Hwei-Fa |
Evaluation of SF3B1 Mutation Screening by High-Resolution Melting Analysis and its Clinical Utility for Myelodysplastic Syndrome with Ring Sideroblasts at the Point of Diagnosis. Laboratory medicine 2018 12 50 (3): 254-262. Mizuta Shumpei, Yamane Noriko, Komai Takao, Koba Yusuke, Ukyo Naoya, Tamekane Akira, Watanabe Mitsuma |
Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes. Oncotarget 2018 1 8 (63): 106948-106961. Cedena M Teresa, Rapado Inmaculada, Santos-Lozano Alejandro, Ayala Rosa, Onecha Esther, Abaigar María, Such Esperanza, Ramos Fernando, Cervera José, Díez-Campelo María, Sanz Guillermo, Rivas Jesús Hernández, Lucía Alejandro, Martínez-López Joaqu |
The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia. American journal of hematology 2019 Jul . Zheng Gang, Chen Ping, Pallavajjalla Aparna, Haley Lisa, Gondek Lukasz, Dezern Amy, Ling Hua, De Marchi Federico, Lin Ming-Tseh, Gocke Christoph |
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes. Blood 2020 9 136 (20): 2249-2262. Nagata Yasunobu, Zhao Ran, Awada Hassan, Kerr Cassandra M, Mirzaev Inom, Kongkiatkamon Sunisa, Nazha Aziz, Makishima Hideki, Radivoyevitch Tomas, Scott Jacob G, Sekeres Mikkael A, Hobbs Brian P, Maciejewski Jaroslaw |
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes. Clinical lymphoma, myeloma & leukemia 2020 3 20 (6): 400-406.e2. Zhang Qing, Haider Mintallah, Al Ali Najla H, Lancet Jeffrey E, Epling-Burnette Pearlie K, List Alan F, Padron Eric, Komrokji Rami |
[Analysis of ASXL1 gene variant in patients with myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020 Feb 37 (2): 110-115. Chen Meiyu, Liu Jie, Chao Hongying, Qin Wei, Jiang Naike, Lu Xuzhang, Cen Ling, Jiang Yu, Cai Xiaohui, Zhang Ri, Wang Qi |
Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Scientific reports 2020 10 10 (1): 18622. Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Ro |
Concomitant isochromosome 17q and mutated SETBP1 in a myelodysplastic syndrome patient with a poor prognosis. International journal of clinical and experimental pathology 2020 1 10 (9): 9786-9792. Xu Qian, Liu Chunxia, Zhang Hao, Liu Huan, Xue Mingming, Zhang Shuling, Liu B |
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. Blood advances 2021 8 5 (17): 3254-3265. van der Werf Inge, Wojtuszkiewicz Anna, Meggendorfer Manja, Hutter Stephan, Baer Constance, Heymans Martijn, Valk Peter J M, Kern Wolfgang, Haferlach Claudia, Janssen Jeroen J W M, Ossenkoppele Gert J, Cloos Jacqueline, Haferlach Torst |
High mutation burden in the checkpoint and micro-RNA processing genes in myelodysplastic syndrome. PloS one 2021 3 16 (3): e0248430. Moiseev Ivan Sergeevich, Tcvetkov Nikolay Yurevich, Barkhatov Ildar Munerovich, Barabanshikova Maria Vladimirovna, Bug Dmitrii Sergeevich, Petuhova Natalya Vitalievna, Tishkov Artem Valerievich, Bakin Evgenyi Alexandrovich, Izmailova Ekaterina Andreevna, Shakirova Alena Igorevna, Kulagin Alexandr Dmitrievich, Morozova Elena Vladislavov |
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations. Clinical lymphoma, myeloma & leukemia 2021 11 22 (5): e293-e299. Polprasert Chantana, Niparuck Pimjai, Rattanathammethee Thanawat, Chuncharunee Suporn, Kobbuaklee Sirorat, Songserm Kritanan, Suksusut Amornchai, Trithiphen Sasinipa, Lanamtieng Theerin, Kongkiatkamon Sunisa, Chanswangphuwana Chantiya, Lawasut Panisinee, Bunworasate Udomsak, Rojnuckarin Ponlap |
Bioinformatics analysis of high frequency mutations in myelodysplastic syndrome-related patients. Annals of translational medicine 2021 11 9 (19): 1491. Wu Kun, Nie Bo, Li Liyin, Yang Xin, Yang Jinrong, He Zhenxin, Li Yanhong, Cheng Shenju, Shi Mingxia, Zeng Y |
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients. Annals of hematology 2021 Jan . Janusz Kamila, Izquierdo Marta Martín, Cadenas Félix López, Ramos Fernando, Sánchez Jesús María Hernández, Lumbreras Eva, Robledo Cristina, Del Real Javier Sánchez, Caballero Juan Carlos, Collado Rosa, Bernal Teresa, Pedro Carme, Insunza Andrés, de Paz Raquel, Xicoy Blanca, Salido Eduardo, García Joaquín Sánchez, Mínguez Sandra Santos, García Cristina Miguel, Muñoz Ana María Simón, Barba Mercedes Sánchez, Rivas Jesús María Hernández, Abáigar María, Campelo María Dí |
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia. European journal of haematology 2021 1 106 (4): 500-507. Jajosky Audrey N, Sadri Navid, Meyerson Howard J, Oduro Kwadwo A, Kelkar Ashwin, Fitzgerald Brynn, Tomlinson Benjamin, Moore Erika M, Beck Rose |
SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome. Clinical lymphoma, myeloma & leukemia 2022 Aug . Falantes Jose F, Márquez-Malaver Francisco J, Carrillo Estrella, Culebras Marta García, Morales Rosario, Prats Concepción, Vargas Maria T, Caballero Teresa, Rodríguez-Arbolí Eduardo, Espigado Ildefonso, Pérez-Simón Jose Anton |
A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation. Frontiers in oncology 2022 7 12 905490. Ma Liya, Liang Bin, Hu Huixian, Yang Wenli, Lin Shengyun, Cao Lihong, Li Kongfei, Kuang Yuemin, Shou Lihong, Jin Weimei, Lan Jianping, Ye Xingnong, Le Jing, Lei Huyi, Fu Jiaping, Lin Ying, Jiang Wenhua, Zheng Zhiying, Jiang Songfu, Fu Lijuan, Su Chuanyong, Yin XiuFeng, Liu Lixia, Qin Jiayue, Jin Jie, Qian Shenxian, Ouyang Guifang, Tong Hongy |
Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome. British journal of haematology 2022 May . Choi Eun-Ji, Cho Young-Uk, Hur Eun-Hye, Park Han-Seung, Choi Yunsuk, Lee Jung-Hee, Lee Kyoo-Hyung, Kim Miyoung, Hwang Sang-Hyun, Jang Seongsoo, Park Chan-Jeoung, Seo Eul-Ju, Lee Je-Hw |
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations. JACC. CardioOncology 2022 Mar 4 (1): 38-49. Calvillo-Argüelles Oscar, Schoffel Alice, Capo-Chichi José-Mario, Abdel-Qadir Husam, Schuh Andre, Carrillo-Estrada Montserrat, Liu Shiying, Gupta Vikas, Schimmer Aaron D, Yee Karen, Shlush Liran I, Natarajan Pradeep, Thavendiranathan Paaladine |
Clinical and Genomic Profiles of Korean Patients with MECOM Rearrangement and the t(3;21)(q26.2;q22.1) Translocation. Annals of laboratory medicine 2022 4 42 (5): 590-596. Lee Jikyo, Kim Sung Min, Kim Soonok, Yun Jiwon, Jeong Dajeong, Lee Young Eun, Roh Eun-Youn, Lee Dong So |
DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation. Frontiers in oncology 2022 3 12 849376. Jawad Majd, Afkhami Michelle, Ding Yi, Zhang Xiaohui, Li Peng, Young Kim, Xu Mina Luqing, Cui Wei, Zhao Yiqing, Halene Stephanie, Al-Kali Aref, Viswanatha David, Chen Dong, He Rong, Zheng Ga |
Clinical characterization of the mutational landscape of 24,639 real-world samples from patients with myeloid malignancies. Cancer genetics 2023 8 278-279 38-49. Grant Hogg, Eric A Severson, Li Cai, Heidi M Hoffmann, Kimberly A Holden, Kerry Fitzgerald, Angela Kenyon, Qiandong Zeng, Michael Mooney, Sabrina Gardner, Wenjie Chen, Narasimhan Nagan, Deborah Boles, Scott Parker, Tamara J Richman, Stanley Letovsky, Henry Dong, Steven M Anderson, Shakti Ramkissoon, Prasanth Reddy, Marcia Eisenberg, Anjen Chenn, Taylor J Jens |
[Clinical features of SF3B1 mutation in patients with myelodysplastic syndrome with excess blasts]. Zhonghua nei ke za zhi 2023 6 62 (6): 681-687. F He, T Li, Y F Li, P Tang, L N Sang, Y M Huang, L Sun, L L |
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia. Blood advances 2023 5 . Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Zoe S Stone-Molloy, Jordan Chervin, Brian J Ball, Zachary D Epstein-Peterson, Maria E Arcila, Aaron J Stonestrom, Andrew Dunbar, Sheng F Cai, Jacob L Glass, Mark B Geyer, Raajit K Rampal, Ellin Berman, Omar I Abdel-Wahab, Eytan M Stein, Martin S Tallman, Ross L Levine, Aaron D Goldberg, Elli Papaemmanuil, Yanming Zhang, Mikhail Roshal, Andriy Derkach, Wenbin Xi |
Co-mutation of ASXL1 and SF3B1 Predicts Poorer Overall Survival Than Isolated ASXL1 or SF3B1 Mutations. In vivo (Athens, Greece) 2023 4 37 (3): 985-993. Jinming Song, Lynn Moscinski, Ethan Yang, Haipeng Shao, Mohammad Hussaini, Hailing Zha |
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes. Scientific reports 2023 2 13 (1): 2641. Konishi Tatsuya, Sadato Daichi, Toya Takashi, Hirama Chizuko, Kishida Yuya, Nagata Akihito, Yamada Yuta, Shingai Naoki, Shimizu Hiroaki, Najima Yuho, Kobayashi Takeshi, Haraguchi Kyoko, Okuyama Yoshiki, Harada Hironori, Ohashi Kazuteru, Harada Yuka, Doki Nori |
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. American journal of hematology 2023 1 98 (3): 398-407. Lee Wan-Hsuan, Lin Chien-Chin, Tsai Cheng-Hong, Tien Feng-Ming, Lo Min-Yen, Ni Sao-Chih, Yao Ming, Tseng Mei-Hsuan, Kuo Yuan-Yeh, Liu Ming-Chih, Tang Jih-Luh, Sun Hsun-I, Chuang Yi-Kuang, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: